Table of Contents
Epilepsy Research and Treatment
Volume 2011 (2011), Article ID 143908, 10 pages
http://dx.doi.org/10.1155/2011/143908
Review Article

Blood-Brain Barrier Dysfunction in Epileptogenesis of the Temporal Lobe

1Departments of Physiology and Neurobiology, Ben-Gurion University of the Negev, Beersheva 84105, Israel
2Neurocure Research Center, Institute of Neurophysiology, Charité Universitätsmedizin, Berlin 10117, Germany
3Biomedical Engineering, Ben-Gurion University of the Negev, Beersheva 84105, Israel

Received 11 October 2010; Accepted 14 March 2011

Academic Editor: Heidrun Potschka

Copyright © 2011 Itai Weissberg et al. This is an open access article distributed under the , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dubé, C. Richichi, R. A. Bender, G. Chung, B. Litt, and T. Z. Baram, “Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis,” Brain, vol. 129, no. 4, pp. 911–922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. N. Banerjee and W. A. Hauser, “Incidence and prevalence,” in Epilepsy a Comprehensive Textbook, J. Engel Jr. and T. A. Pedley, Eds., pp. 45–56, Lippincot Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2008. View at Google Scholar
  3. W. A. Hauser, J. F. Annegers, and W. A. Rocca, “Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota,” Mayo Clinic Proceedings, vol. 71, no. 6, pp. 576–586, 1996. View at Google Scholar · View at Scopus
  4. G. Stoll, C. Kleinschnitz, S. G. Meuth et al., “Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 2, pp. 331–341, 2009. View at Publisher · View at Google Scholar
  5. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, “Pathobiology of ischaemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul, “Targets for vascular protection after acute ischemic stroke,” Stroke, vol. 35, no. 9, pp. 2220–2225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. F. Fabene, G. N. Mora, M. Martinello et al., “A role for leukocyte-endothelial adhesion mechanisms in epilepsy,” Nature Medicine, vol. 14, no. 12, pp. 1377–1383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Smith and E. D. Hall, “Mild pre- and posttraumatic hypothermia attenuates blood-brain barrier damage following controlled cortical impact injury in the rat,” Journal of Neurotrauma, vol. 13, no. 1, pp. 1–9, 1996. View at Google Scholar · View at Scopus
  9. E. Grillon, P. Provent, O. Montigon, C. Segebarth, C. Rémy, and E. L. Barbie, “Blood-brain barrier permeability to manganese and to Gd-DOTA in a rat model of transient cerebral ischaemia,” NMR in Biomedicine, vol. 21, no. 5, pp. 427–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. N. Nagaraja, K. A. Keenan, J. D. Fenstermacher, and R. A. Knight, “Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood-brain barrier,” Microcirculation, vol. 15, no. 1, pp. 1–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Huang, U. M. Upadhyay, and R. J. Tamargo, “Inflammation in stroke and focal cerebral ischemia,” Surgical Neurology, vol. 66, no. 3, pp. 232–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. P. M. Lenzlinger, M. C. Morganti-Kossmann, H. L. Laurer, and T. K. McIntosh, “The duality of the inflammatory response to traumatic brain injury,” Molecular Neurobiology, vol. 24, no. 1–3, pp. 169–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. O. I. Schmidt, M. C. Morganti-Kossmann, C. E. Heyde et al., “Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury,” Journal of Neuroinflammation, vol. 1, article 13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Pan, S. Xiang, H. Tu, and A. J. Kastin, Cytokines Interact with the Blood-Brain Barrier, Wiley-VCH Verlag GmbH & Co. KGaA, 2006.
  15. N. Ferrara, “VEGF and the quest for tumour angiogenesis factors,” Nature Reviews Cancer, vol. 2, no. 10, pp. 795–803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. K. H. Plate, G. Breier, H. A. Weich, H. D. Mennel, and W. Risau, “Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms,” International Journal of Cancer, vol. 59, no. 4, pp. 520–529, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. S. D. Croll, R. M. Ransohoff, N. Cai et al., “VEGF-mediated inflammation precedes angiogenesis in adult brain,” Experimental Neurology, vol. 187, no. 2, pp. 388–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. K. Jain, E. Di Tomaso, D. G. Duda, J. S. Loeffler, A. G. Sorensen, and T. T. Batchelor, “Angiogenesis in brain tumours,” Nature Reviews Neuroscience, vol. 8, no. 8, pp. 610–622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Dore-Duffy and J. C. LaManna, “Physiologic angiodynamics in the brain,” Antioxidants & Redox Signaling, vol. 9, no. 9, pp. 1363–1371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Hara and I. Okayasu, “Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance,” Acta Neuropathologica, vol. 108, no. 1, pp. 43–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Cross and L. Claesson-Welsh, “FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition,” Trends in Pharmacological Sciences, vol. 22, no. 4, pp. 201–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Gerwins, E. Skoldenberg, and L. Claesson-Welsh, “Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis,” Critical Reviews in Oncology/Hematology, vol. 34, no. 3, pp. 185–194, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, “Vascular-specific growth factors and blood vessel formation,” Nature, vol. 407, no. 6801, pp. 242–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. A. MacIntyre, C. J. Hammond, C. S. Little, D. M. Appelt, and B. J. Balin, “Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells,” FEMS Microbiology Letters, vol. 217, no. 2, pp. 167–172, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Verma, Y. Lo, M. Chapagain et al., “West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier,” Virology, vol. 385, no. 2, pp. 425–433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. W. A. Hauser, “Status epilepticus: epidemiologic considerations,” Neurology, vol. 40, no. 5, pp. 9–13, 1990. View at Google Scholar · View at Scopus
  27. C. M. Dubé, A. L. Brewster, C. Richichi, Q. Zha, and T. Z. Baram, “Fever, febrile seizures and epilepsy,” Trends in Neurosciences, vol. 30, no. 10, pp. 490–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Scantlebury and J. G. Heida, “Febrile seizures and temporal lobe epileptogenesis,” Epilepsy Research, vol. 89, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Rigau, M. Morin, M. C. Rousset et al., “Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy,” Brain, vol. 130, no. 7, pp. 1942–1956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. van Vliet, S. D. C. Araújo, S. Redeker, R. van Schaik, E. Aronica, and J. A. Gorter, “Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy,” Brain, vol. 130, no. 2, pp. 521–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. De Simoni, C. Perego, T. Ravizza et al., “Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus,” European Journal of Neuroscience, vol. 12, no. 7, pp. 2623–2633, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Folbergrová, M. Ingvar, and B. K. Siesjö, “Metabolic changes in cerebral cortex, hippocampus, and cerebellum during sustained bicuculline-induced seizures,” Journal of Neurochemistry, vol. 37, no. 5, pp. 1228–1238, 1981. View at Google Scholar · View at Scopus
  33. E. Oby and D. Janigro, “The blood-brain barrier and epilepsy,” Epilepsia, vol. 47, no. 11, pp. 1761–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Marchi, Q. Fan, C. Ghosh et al., “Antagonism of peripheral inflammation reduces the severity of status epilepticus,” Neurobiology of Disease, vol. 33, no. 2, pp. 171–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Marchi, E. Oby, A. Batra et al., “In vivo and in vitro effects of pilocarpine: relevance to ictogenesis,” Epilepsia, vol. 48, no. 10, pp. 1934–1946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Friedman, D. Kaufer, and U. Heinemann, “Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy,” Epilepsy Research, vol. 85, no. 2-3, pp. 142–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Ivens, D. Kaufer, L. P. Flores et al., “TGF-β receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis,” Brain, vol. 130, no. 2, pp. 535–547, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Seifert, K. Schilling, and C. Steinhäuser, “Astrocyte dysfunction in neurological disorders: a molecular perspective,” Nature Reviews Neuroscience, vol. 7, no. 3, pp. 194–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Tomkins, O. Friedman, S. Ivens et al., “Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex,” Neurobiology of Disease, vol. 25, no. 2, pp. 367–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. L. P. Cacheaux, S. Ivens, Y. David et al., “Transcriptome profiling reveals TGF-β signaling involvement in epileptogenesis,” Journal of Neuroscience, vol. 29, no. 28, pp. 8927–8935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. David, L. P. Cacheaux, S. Ivens et al., “Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?” Journal of Neuroscience, vol. 29, no. 34, pp. 10588–10599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Marchi, L. Angelov, T. Masaryk et al., “Seizure-promoting effect of blood-brain barrier disruption,” Epilepsia, vol. 48, no. 4, pp. 732–742, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Marchi, Q. Teng, C. Ghosh et al., “Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity,” Brain Research, vol. 1353, pp. 176–186, 2010. View at Publisher · View at Google Scholar
  44. J. A. Gorter, P. M. Gonçalves Pereira, E. A. van Vliet, E. Aronica, F. H. Lopes da Silva, and P. J. Lucassen, “Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures,” Epilepsia, vol. 44, no. 5, pp. 647–658, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. D. G. Fujikawa, “Prolonged seizures and cellular injury: understanding the connection,” Epilepsy & Behavior, vol. 7, pp. S3–S11, 2005. View at Google Scholar · View at Scopus
  46. M. Gekle, P. Knaus, R. Nielsen et al., “Transforming growth factor-β reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells,” The Journal of Physiology, vol. 552, no. 2, pp. 471–481, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. S. Siddiqui, Z. K. Siddiqui, and A. B. Malik, “Albumin endocytosis in endothelial cells induces TGF-β receptor II signaling,” American Journal of Physiology, vol. 286, no. 5, pp. L1016–L1026, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Luo, A. H. Lin, E. Masliah, and T. Wyss-Coray, “Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18326–18331, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. K. A. Ata, F. Lennmyr, K. Funa, Y. Olsson, and A. Terént, “Expression of transforming growth factor-β1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: an immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery,” Acta Neuropathologica, vol. 97, no. 5, pp. 447–455, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. P. G. Matz, A. Lewén, and P. H. Chan, “Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 8, pp. 921–928, 2001. View at Google Scholar · View at Scopus
  51. C. Hooper, F. Pinteaux-Jones, V. A. H. Fry et al., “Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage,” Journal of Neurochemistry, vol. 109, no. 3, pp. 694–705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Maggio, E. Shavit, J. Chapman, and M. Segal, “Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults,” Journal of Neuroscience, vol. 28, no. 3, pp. 732–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Seiffert, J. P. Dreier, S. Ivens et al., “Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex,” Journal of Neuroscience, vol. 24, no. 36, pp. 7829–7836, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Pitsch, S. Schoch, N. Gueler, P. J. Flor, H. van der Putten, and A. J. Becker, “Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy,” Neurobiology of Disease, vol. 26, no. 3, pp. 623–633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Nadal, J. Y. Sul, M. Valdeolmillos, and P. A. McNaughton, “Albumin elicits calcium signals from astrocytes in brain slices from neonatal rat cortex,” The Journal of Physiology, vol. 509, no. 3, pp. 711–716, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. C. L. Floyd and B. G. Lyeth, “Astroglia: important mediators of traumatic brain injury,” in Neurotrauma: New Insights into Pathology and Treatment, J. T. Weber and A. I. R. Mass, Eds., vol. 161 of Progress in Brain Research, pp. 61–79, Elsevier, New York, NY, USA, 2007. View at Google Scholar
  57. U. Heinemann, S. Gabriel, R. Jauch et al., “Alterations of glial cell function in temporal lobe epilepsy,” Epilepsia, vol. 41, no. 6, pp. S185–S189, 2000. View at Google Scholar · View at Scopus
  58. R. Jabs, G. Seifert, and C. Steinhäuser, “Astrocytic function and its alteration in the epileptic brain,” Epilepsia, vol. 49, no. 2, pp. 3–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Wetherington, G. Serrano, and R. Dingledine, “Astrocytes in the Epileptic Brain,” Neuron, vol. 58, no. 2, pp. 168–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Ç. Eroglu, N. J. Allen, M. W. Susman et al., “Gabapentin receptor α2δ-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis,” Cell, vol. 139, no. 2, pp. 380–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Filosa, S. Paixo, S. D. Honsek et al., “Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport,” Nature Neuroscience, vol. 12, no. 10, pp. 1285–1292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Henneberger, T. Papouin, S. H. R. Oliet, and D. A. Rusakov, “Long-term potentiation depends on release of d-serine from astrocytes,” Nature, vol. 463, no. 7278, pp. 232–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. D'Ambrosio, D. O. Maris, M. S. Grady, H. R. Winn, and D. Janigro, “Impaired K+ homeostasis and altered electrophysiological properties of post-traumatic hippocampal gila,” Journal of Neuroscience, vol. 19, no. 18, pp. 8152–8162, 1999. View at Google Scholar · View at Scopus
  64. D. K. Binder, X. Yao, Z. Zador, T. J. Sick, A. S. Verkman, and G. T. Manley, “Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels,” Glia, vol. 53, no. 6, pp. 631–636, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. D. K. Binder, K. Oshio, T. Ma, A. S. Verkman, and G. T. Manley, “Increased seizure threshold in mice lacking aquaporin-4 water channels,” NeuroReport, vol. 15, no. 2, pp. 259–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Djukic, K. B. Casper, B. D. Philpot, L. S. Chin, and K. D. McCarthy, “Conditional knock-out of K4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation,” Journal of Neuroscience, vol. 27, no. 42, pp. 11354–11365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Gabriel, A. Eilers, A. Kivi et al., “Effects of barium on stimulus induced changes in extracellular potassium concentration in area CA1 of hippocampal slices from normal and pilocarpine-treated epileptic rats,” Neuroscience Letters, vol. 242, no. 1, pp. 9–12, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. W. Schröder, S. Hinterkeuser, G. Seifert et al., “Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy,” Epilepsia, vol. 41, no. 6, pp. S181–S184, 2000. View at Google Scholar · View at Scopus
  69. A. Wallraff, R. Köhling, U. Heinemann, M. Theis, K. Willecke, and C. Steinhäuser, “The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus,” Journal of Neuroscience, vol. 26, no. 20, pp. 5438–5447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Bezzi, M. Domercq, L. Brambilla et al., “CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity,” Nature Neuroscience, vol. 4, no. 7, pp. 702–710, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. G. F. Tian, H. Azmi, T. Takano et al., “An astrocytic basis of epilepsy,” Nature Medicine, vol. 11, no. 9, pp. 973–981, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Eid, M. J. Thomas, D. D. Spencer et al., “Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy,” The Lancet, vol. 363, no. 9402, pp. 28–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Eid, A. Ghosh, Y. Wang et al., “Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats,” Brain, vol. 131, no. 8, pp. 2061–2070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Vezzani and T. Z. Baram, “New roles for interleukin-1 beta in the mechanisms of epilepsy,” Epilepsy Currents, vol. 7, pp. 45–50, 2007. View at Google Scholar
  75. A. T. Argaw, Y. Zhang, B. J. Snyder et al., “IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program,” Journal of Immunology, vol. 177, no. 8, pp. 5574–5584, 2006. View at Google Scholar · View at Scopus
  76. A. Vezzani, D. Moneta, M. Conti et al., “Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 21, pp. 11534–11539, 2000. View at Google Scholar · View at Scopus
  77. A. Vezzani, M. Conti, A. De Luigi et al., “Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures,” Journal of Neuroscience, vol. 19, no. 12, pp. 5054–5065, 1999. View at Google Scholar · View at Scopus
  78. N. J. Abbott, L. Rönnbäck, and E. Hansson, “Astrocyte-endothelial interactions at the blood-brain barrier,” Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Yu and P. Shinnick-Gallagher, “Interleukin-1β inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons,” Journal of Pharmacology and Experimental Therapeutics, vol. 271, no. 2, pp. 590–600, 1994. View at Google Scholar · View at Scopus
  80. B. Viviani, S. Bartesaghi, F. Gardoni et al., “Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases,” Journal of Neuroscience, vol. 23, no. 25, pp. 8692–8700, 2003. View at Google Scholar · View at Scopus
  81. B. Viviani, F. Gardoni, and M. Marinovich, “Cytokines and neuronal ion channels in health and disease,” in International Review of Neurobiology Neuroinflammation in Neuronal Death and Repair, G. Bagetta, M. T. Corasaniti, and S. A. Lipton, Eds., vol. 82, pp. 247–263, Academic Press, New York, NY, USA, 2007. View at Google Scholar
  82. S. Wang, Q. Cheng, S. Malik, and J. Yang, “Interleukin-1β inhibits γ-aminobutyric acid type A (GABAA) receptor current in cultured hippocampal neurons,” Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 2, pp. 497–504, 2000. View at Google Scholar · View at Scopus
  83. J. M. Parent, R. C. Elliott, S. J. Pleasure, N. M. Barbaro, and D. H. Lowenstein, “Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy,” Annals of Neurology, vol. 59, no. 1, pp. 81–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Ben-Hur, O. Ben-Menachem, V. Furer, O. Einstein, R. Mizrachi-Kol, and N. Grigoriadis, “Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells,” Molecular and Cellular Neuroscience, vol. 24, no. 3, pp. 623–631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. J. W. Koo and R. S. Duman, “IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 2, pp. 751–756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Battista, C. C. Ferrari, F. H. Gage, and F. J. Pitossi, “Neurogenic niche modulation by activated microglia: transforming growth factor β increases neurogenesis in the adult dentate gyrus,” European Journal of Neuroscience, vol. 23, no. 1, pp. 83–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Mathieu, A. P. Piantanida, and F. Pitossi, “Chronic expression of transforming growth factor-beta enhances adult neurogenesis,” NeuroImmunoModulation, vol. 17, no. 3, pp. 200–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. O. Tomkins, I. Shelef, I. Kaizerman et al., “Blood-brain barrier disruption in post-traumatic epilepsy,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 7, pp. 774–777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Baltes, A. M. Gastens, M. Fedrowitz, H. Potschka, V. Kaever, and W. Löscher, “Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein,” Neuropharmacology, vol. 52, no. 2, pp. 333–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. N. Marchi, J. Gonzalez-Martinez, M. T. Nguyen, T. Granata, and D. Janigro, “Transporters in drug-refractory epilepsy: clinical significance,” Clinical Pharmacology and Therapeutics, vol. 87, no. 1, pp. 13–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. W. Löscher and H. Potschka, “Drug resistance in brain diseases and the role of drug efflux transporters,” Nature Reviews Neuroscience, vol. 6, no. 8, pp. 591–602, 2005. View at Publisher · View at Google Scholar · View at Scopus